Loading...
Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I
Myotonic dystrophy type I (DM1) is a disabling multisystemic disease that predominantly affects skeletal muscle. It is caused by expanded CTG repeats in the 3′-UTR of the dystrophia myotonica protein kinase (DMPK) gene. RNA hairpins formed by elongated DMPK transcripts sequester RNA-binding proteins...
Na minha lista:
| Udgivet i: | J Clin Invest |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5272183/ https://ncbi.nlm.nih.gov/pubmed/28067669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI89616 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|